Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Prostatic Neoplasms 3Multiple Myeloma 3Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Mouth Neoplasms 2Head and Neck Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Tobacco Use Cessation 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Splenomegaly 1Smoking Cessation 1Neoplasm Metastasis 1Meningioma 1Lymphocytosis 1Lymphadenopathy 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Gynecologic Oncology Patient 1Gastrointestinal Neoplasms 1Fever 1Fatigue 1Fallopian Tube Neoplasms 1Depression 1Dental Caries 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Metformin 1Mannose-Binding Lectin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Fever × Surveys and Questionnaires × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡